Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Acylation. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN116554014B reveals high-purity fenofibrate preparation with improved impurity control and scalable commercial manufacturing capabilities for global supply chains.
Patent CN112250611B reveals a novel Friedel-Crafts route for Larotrectinib intermediates. Achieve high purity and cost reduction in API manufacturing with scalable chemistry.
Patent CN104072347A reveals a cost-effective synthesis route for 4-alkoxy-1,1,1-trifluoro-3-butanone. This method ensures high purity and scalable production for global supply chains.
Novel preparation method for Silodosin intermediate via CN104974072A. Offers cost reduction and scalable manufacturing for pharmaceutical supply chains.
Advanced synthesis of 1-(4-chlorophenyl)-2-cyclopropyl-1-acetone via safe epoxidation-rearrangement. High-purity agrochemical intermediate supplier offering cost-effective production.
Novel chlorination route avoids bromine, ensuring high purity >99% and cost reduction in UV curing material manufacturing for global supply chains.
Patent CN100569790C reveals a high-yield 3-step route for Capecitabine intermediates using triphosgene, offering significant cost reduction and scalability for pharmaceutical manufacturing.
Patent CN109678707B reveals a robust 4-step synthesis for D3-Salbutamol. Achieve >98% isotopic purity for food safety testing with cost-effective scalable methods.
Novel 4-step route for D3-salbutamol from ethyl salicylate. >98% purity and isotope abundance for food safety testing standards.
Novel patent CN110627683A offers safe, high-purity 4-cyano-1-indanone synthesis. Eliminates toxic cyanating reagents for cost-effective pharmaceutical intermediate manufacturing.
Patent CN105153137A reveals a cost-effective Empagliflozin synthesis route. Enhance supply chain reliability with high-purity pharmaceutical intermediates.
Patent CN103772276B reveals an eco-friendly synthesis route for this aldose reductase inhibitor intermediate, offering significant cost reduction and supply chain reliability for pharmaceutical manufacturing.
Novel green synthesis route for carbazole-benzimidazole derivatives with >90% yield. Cost-effective pharma intermediate manufacturing.
Patent CN101337970B details a novel synthesis for Cefpirome Sulfate offering high purity and scalable production for reliable antibiotic intermediate supply chains.
Novel Suzuki coupling route for Canagliflozin intermediate. Enhances purity and scalability for pharmaceutical supply chains. Reliable manufacturing partner.
Patent CN102408401B details a scalable total synthesis of Cochinchinenin B, offering a sustainable alternative to plant extraction for analgesic drug development.
Patent CN108314689A details a regioselective synthesis for 4,11-diacyl bergenin. This method offers significant cost reduction and supply chain reliability for pharmaceutical manufacturing.
Novel one-pot synthesis method for 2-acetylcyclohexanone ensures high purity and yield. Offers significant cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing globally.
New patent CN102786399A offers greener synthesis for 2,7-dichloro-4-chloroacetylfluorene. Enhances supply chain reliability and reduces manufacturing costs significantly.
Novel pH-controlled process for pyrazolone derivatives improves yield and selectivity for agrochemical manufacturing supply chains.